What will the average number of measles cases be during Trump's term?

**Stage 1 — Blind analysis (ignore market prices)**

Summary of the evidence: the strongest hard fact is that 2026 has already recorded 2,030 confirmed measles cases as of early June. That single-year figure is well above the post-2020 baseline and demonstrates that intense outbreak activity is possible in the current epidemiological and policy environment. Reports also note tens of outbreaks (30 in 2026 so far; 48 for all of 2025), and public-health commentary highlights clustering tied to pockets of low vaccination coverage.

Key statistical reasoning (independent of market): if the binary "Yes" outcome corresponds to the commonly implied threshold in the news context — an average annual case count of ≧ 2,000 across 2025–2028 — then the term-total must be ≥ 8,000 cases. With 2026 already at ~2,030, the remaining three years would need to average ≈ 1,990–2,000 each. Historically, measles incidence in the U.S. since 2020 has been much lower, so producing three additional 2,000-case years in 2025, 2027 and 2028 would require sustained, large outbreaks driven by persistent vaccination gaps, repeated importations, or systematic policy/regulatory changes that reduce immunity or outbreak control capacity.

Arguments pushing probability up include the demonstrated 2026 surge, documented clusters of under-vaccinated communities, and the evident policy attention that could either increase or decrease vaccination coverage depending on direction of policy and enforcement. Arguments pushing probability down include the vaccine-preventable nature of measles, proven public-health interventions (ring vaccination, school exclusion, outbreak response teams) that historically suppress transmission once outbreaks are identified, and the fact that a single bad year does not mechanically create three more bad years unless structural drivers persist or worsen.

Putting these together, my independent estimate that the four-year average ≥ 2,000/year is 15%. This reflects that a single high year (2026) materially raises the floor but is insufficient on its own to push the four-year average to the 2,000+/yr range without continued, substantial outbreaks.

**Stage 2 — Market calibration (considering current market prices)**

Current market: Yes = 0.31, No = 0.69. My independent 0.15 is materially lower than the market's 0.31. Possible reasons the market is pricing a higher 'Yes' probability:

- *Recency / momentum bias*: traders overweight the very recent and visible 2026 count (2,030) and extrapolate it forward as a new baseline rather than a single severe year. - *Ambiguity about the resolution threshold*: if some traders misunderstand whether the market is asking about the *average across years* vs. *some-year exceeding X*, they may bid 'Yes' differently. Misunderstanding tends to inflate trade volume on the more intuitive interpretation ("Will there be a high measles era?"). - *Risk aversion / hedging*: institutional players (public-health NGOs, reporters) who stress-test worst-case scenarios may buy 'Yes' as a hedge against future adverse announcements or to signal concern; that activity can lift the price above what epidemiological fundamentals alone justify. - *Tail-risk pricing for policy changes*: some traders may believe recent federal-level policy signals (moves to alter vaccine policy, reductions in enforcement, or deregulation) materially increase the chance of sustained high transmission; if they overweight policy risk, they will push 'Yes' higher.

Given these plausible behavioral and informational drivers, I read the market price as reflecting a mix of legitimate concern about sustained outbreaks plus cognitive biases and possible ambiguity about the bet's exact resolution criteria. My model leans substantially toward treating 2026 as a severe but not necessarily persistent outlier, so I view the market as likely overpricing the long-term persistence of this outbreak.

Recommendation: if you trade on this market, confirm the exact resolution threshold (the numeric cutoff for 'Yes') and whether the average is arithmetic across calendar years 2025–2028. If the cutoff is indeed ≧2,000/year, the market appears to offer value on the 'No' side given my 15% estimate for 'Yes'.